---
$id: https://graph.org.ai/products/commodity/51392701
$type: Product
source: UNSPSC
code: "51392701"
title: "Saterinone"
class: "51392700"
classTitle: "Sympathomimetic or adrenergic piperazines"
family: "51390000"
familyTitle: "Sympathomimetic or adrenergic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Saterinone

**UNSPSC Code**: 51392701
**Class**: [Sympathomimetic or adrenergic piperazines](Sympathomimetic or adrenergic piperazines.mdx)
**Family**: [Sympathomimetic or adrenergic drugs](../Sympathomimetic or adrenergic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a phosphodiesterase inhibitor with the molecular formula C27H30N4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier W4P85FO7GS, chemically known as (+-)-1,2-dihydro-5-(p-(2-hydroxy-3-(4-(o-methoxyphenyl)-1-piperazinyl)propoxy)phenyl)-6-methyl-2-oxonicotinonitrile but generally known as saterinone, which bears US NIH Compound Identifier 65874. European Medicines Agency schedules Saterinone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10457MIG. The term SATERINONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 1, No. 4, 1987, List 27). SATERINONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule saterinone under HS 29337900 and SITC 51561. As of Q4 2014, SATERINONE remains the US FDA Preferred Term for this commodity. Saterinone bears US NLM identifiers UMLS ID C0074082 and NCI Concept Code C74348. SMILES: OC(CN1CCN(CC1)C1C(OC)CCCC1)COC1CCC(CC1)C1C([NH]C(=O)C(C1)C#N)C.

